Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Will action start today - what is the trigger?
best, i
Raam08 -
your not alone with your opinion.
but what to do, besides hoping to find a slot to get off?
for sure that is not good news.
pix
hi lido,
here is why: http://www.otcmarkets.com/stock/CLSC/news
...a temporary suspension. will be lifted Aug 23rd.
that is highly unprofessional, but i would not say lethal.
at this point i personally think that clsc is next to a binary event - either make it or break.
what counts for cobalis could be the given investment and potential of Chaim Z. Stern, and of course the Radovich family interests.
In their last PRs Cobalis mentioned some potential new product revenue streams and some new US distribution channels, but this all takes time.
Question is if the court will grant this time, but again i can not believe the Angel will let die Cobalis because of some missing 100Ks a month.
So bottom line: the parties are playing on time - time necessary for the court to get a decision on the claims Cobalis put on YA.
A ruling on these ones could change everything.
JMHO,
best pix
wheredmymoneygo - yes pls can you post that?
TIA pix
this should be just the beginning.
law suit settlement might bring more than just leveling the debt.
will there be a buy back of shares, too?
what is next then? tv infomercials?
prehistin in different formulations for different markets?
other new products?
what could be the value of prehistin in allergy?
25% of americans may develop allergies - roughly 80 millions
0.1% market share, 3 packages prehistin per individual per year
800.000 patients x USD 50 = USD 12.000.000
33% profit margin = USD 4.000.000
100 Mio shares, 20X earnings = pps USD 0.80
this is done with in average 15.000 patients per state
all just IMHO
best, pix
continued:
NAD noted that the claims avoid asserting that PreHistin will result in symptom relief. NAD also
found that these studies support the claim that, "Yes. PreHistin has been clinically tested for several
years by well known U.S. allergists."
As to the claim that "PreHistin helps build up your immune system and has been shown to keep
working for weeks after you stop taking it,” NAD was satisfied that the B12 supplementation, in fact,
helps build one’s immune system, but found insufficient support for the claim that it works for
“weeks after you stop taking it,” and recommended that the advertiser discontinue that part of the
claim.
Based on the fact that none of the participants in the studies taking PreHistin reported any side
effects, NAD found the claims related to side-effects were supported by the evidence in the record.
Further, NAD determined that because PreHistin is essentially a Vitamin B12 supplement, the “All
Natural Formula” was supported.
As to the claim that PreHistin is “Allergist Recommended,” although the advertiser presented a list of
allergists that use and recommend PreHistin to patients, the list did rise to the level of survey of
physicians that would be required to support a “doctor recommended” claim. NAD recommended the
claim be discontinued.
The company, in its advertiser’s statement, said it is “pleased to conform to NAD's recommendations
… and will make such changes, modifications or deletions of claims as appropriate to continually
assure that all such claims are truthful and well substantiated to the public.”
NAD's inquiry was conducted under NAD/CARU/NARB Procedures for the Voluntary Self-Regulation of
National Advertising. Details of the initial inquiry, NAD's decision, and the advertiser's response will be
included in the next NAD/CARU Case Report.
###
About Advertising Industry Self-Regulation: The National Advertising Review Council (NARC) was formed in 1971 by the
Association of National Advertisers, Inc. (ANA), the American Association of Advertising Agencies, Inc. (AAAA), the American
Advertising Federation, Inc. (AAF), and the Council of Better Business Bureaus, Inc. (CBBB). Its purpose is to foster truth and
accuracy in national advertising through voluntary self-regulation. NARC is the body that establishes the policies and
procedures for the CBBB’s National Advertising Division (NAD) and Children’s Advertising Review Unit (CARU), as well as for
the National Advertising Review Board (NARB) and the Electronic Retailing Self-Regulation Program (ERSP).
NAD and CARU are the investigative arms of the advertising industry’s voluntary self-regulation program. Their casework
results from competitive challenges from other advertisers, and also from self-monitoring traditional and new media. The
National Advertising Review Board (NARB), the appeals body, is a peer group from which ad-hoc panels are selected to
adjudicate those cases that are not resolved at the NAD/CARU level. This unique, self-regulatory system is funded entirely by
the business community; CARU is financed by the children’s advertising industry, while NAD/NARC/NARB’s sole source of
funding is derived from membership fees paid to the CBBB. ERSP’s funding is derived from membership in the Electronic
Retailing Association. For more information about advertising self regulation, please visit www.narcpartners.org.
very soon - look at this info from a yahoo poster:
NAD® News
For Immediate Release
Contact: Linda Bean
212-705-0129
NAD DETERMINES COBALIS CAN SUPPORT FOR CERTAIN ADVERTISING CLAIMS
FOR ‘PREHISTIN,’ RECOMMENDS ADVERTISER MODIFY CERTAIN CLAIMS
New York, New York – Jan. 25, 2010 – The National Advertising Division of the Council of Better
Business Bureaus has had determined that Cobalis Corporation can support certain claims for the
company’s “PreHistin” dietary supplement product, but recommended the company modify or
discontinue certain claims.
NAD, the advertising industry’s self-regulatory forum, has expanded its review of advertising for
dietary supplements through an initiative with the Council for Responsible Nutrition.
NAD examined print advertising claims for PreHistin that included:
? "PreHistin is the World's First Pre Histamine."
? "Allergist Recommended,
? “All Natural Formula."
? "PreHistin is a "pre-histamine" which means it regulates the release of histamine."
? "PreHistin was clinically shown to effectively maintain healthy IgE levels which have been
linked to allergy symptoms such as sneezing, nasal congestion, and runny nose."
? "PreHistin has been shown to effectively regulate IgE levels in individuals while
significantly increasing serum vitamin B12 levels."
? "PreHistin helps build up your immune system and has been shown to keep working for
weeks after you stop taking it.”
? "Yes. PreHistin has been clinically tested for several years by well known U.S. allergists."
? "PreHistin is free from side effects such as drowsiness.”
? “Clinical studies using PreHistin showed no side effects when compared to the placebo."
NAD noted in its decision that PreHistin is Vitamin B12 dietary supplement, taken under one’s
tongue, that intended to raise serum B12 levels and lower serum levels of Immunoglobulin E, a class
of antibody that plays an important role in allergy response in the human body.
In contrast to commonly marketed antihistamines for allergies treatment, PreHistin is intended to
work prior to the release of histamines by lowering IgE levels and, in turn, lessening allergy
symptoms and that mechanism of action is reflected in a number of the claims at issue, including
claims that “PreHistin is a "pre-histamine" which means it regulates the release of histamine.” and
“PreHistin is the World's First Pre Histamine.”
Because the product has a unique mechanism of action, NAD found it important that the advertiser
continue to include such explanatory language in its advertising. Further, NAD recommended that
the advertiser make clear that the product, in order to be effective, must be taken prior to allergy
season and not in response to an allergy attack.
Following its review of the evidence in the record, NAD determined that the results of the
advertiser’s clinical studies supported the claims that "PreHistin was clinically shown to effectively
maintain healthy IgE levels which have been linked to allergy symptoms such as sneezing, nasal
congestion, and runny nose.” and "PreHistin has been shown to effectively regulate IgE levels in
individuals while significantly increasing serum vitamin B12 levels.”
this is from a quaterly:
Orders for the MedClean system are contracted by purchase order and are billed in 3 increments. Historically, we bill our customers for 25% of the contact value at signing, 50% when the equipment is shipped to the customer and 25% upon completion of installation and start-up. Consumables and component parts are billed when shipped and service contracts are invoiced at the start of the service period and revenue is pro-rated over the life of the contract.
best, pix
abby - what is happening today?
at least ihub shows the trades neither as buy nor sell - but simply put a ?
what does this mean
TIA
Pix
this guy is a multi millionair - his investment with cobals is more than 1. mio usd up to now.
i am confident that at least his informations of our status and outlook are profund.
looking forward to the launch of the tv infomercials and the court showdown in march.
if positive court outcome may be some interesting deals on the horizon.
best, pix
BiomedReports: about 1 Month ago
MCLN was recently awarded a substantial MedAssets Supply Chain Systems Contract. Thanks to orders from hospitals and clinics, MCLN's management team has informed us that they are running at full capacity and still experiencing an accumulation of unfilled orders.
This need time to mature.
Best Pix
mad greek - what does that mean now?
any idea?
best, pix
so, if they invest USD 7500000 into MCLN for the exchange of 750 preferred shares - their profit is directly linked to the success of MCLN - they must be very sure, that this company develops nicely - because per se they only win with a delta of share price
comments wellcome
pix
kingfisher,
not sure about your interpretation: mine is:
if they deliver USD 1000000 and get 100 preferred shares, they get the right (warrant, within 5 years) to BUY common shares valued 1350000 at the market price of the day of notice.
if share price moves may be to USD 1 in a year- they then can buy in the amount of 1350000 common shares for let us say 0.04 fictional) - this is then their profit.
this is my understanding - any comments?
pix
that is possible - i would prefer to hear something about order status - because this then shows the organnic growth.
as well it will be interesting to hear about the premier deal,
medassets & vestara like
pix
no news - sideway direction
news - next level up
is it that easy?
pix
contracts in 2009?
i find it interesting, that during 2009 (Feb) only one contract was PR'd - but it was stated, that they are running at full capacity, which means 4 systems in parallel...
hope that management update on the full number of orders soon.
pix
moving up - testing resistance again.
pix
Hi Everybody -
hopefully today will pave the way for an unanimously approval of the cobalis plan.
if accepted, we will get hopefully some info on what is going on in the company, as i believe, all possible developments have been holded back up to now, if there are any...
will there be some sort of suprises - we shall see quite soon.
pix
i have now the id and password - but how do i find that,
would be nice to get that info from you.
thx, pix
please be so kind and provide this plan - as you have already got it.
best, pix
what was the otcome of the status conference yesterday?
has anybody participated?
best, pix
sorry - now they need to show a plan to stay in 11 or to be released?
pix
there is no tentative on status conference.
i thought that under status conference they would release cobalis from the 7 to the 11, based on the presented plan of reorg.
hope that today brings clarity.
best, pix
fluke - i have no info - we should know by end of july - latest mid of august.
thumb up or down.
pix
one more side note: since about 2 months no migraine attack,
which can result as well from allergies...
i believe this product works - but completely different than any other medicine out there. unfortunately there is not too much science behind to show to the scientific community.
they may settle now the conflict with ya and in parallel start with the ads in mass media - this may create awareness and sales - not sure if they are able to go it alone - may be partnering later.
pix
what is going on - i do not get it - do not understand the strategy...
http://pacerla.cacb.uscourts.gov/ciaoposted/pdfmain.aspx?pdf=TA_071309.pdf
any comment on this?
best, pix
i used the product for about 30 days now and feel great. symptoms are very mild and as such neglectable. could even eat some fruits i could not eat for years without having troubles - will go on with the product.
they will make it, but sales take time, intelligent structures and marketing money...
pix
mr messiah - yes, if they have the money in the back and a robust business plan, this may work out.
will be interesting to watch how the debt of YA will be handled...one time payment with discount(????) or a number of rates.
anyway getting out of this legal dispute may be the basis for agressive promo of prehistin, further products and clinical trials.
nevertheless i feel that stock price will rebound only slowly...
best, pix
TWO NEW DEADLINES:
13.Juli: deposit of USD 300000 necessary, otherwise conversion
6. August: presentation of reorg plan, if not (acceptable) conversion
now chaz needs to deliver.
still hopeful.
pix
anyway - a start
pix
looks like the company has been revitalized - patents nearly all over industrialized world - japan missing link may follow.
now it is important to spread prehistin info to the public, marketing at its best - cloud marketing, to iniate brand recognition - then followed by easy access messages...
reality check: it is only the beginning - no success guaranteed...
let us cross our fingers for coming week, but more important to get rid of our debt...and consequently corne....
pix
Hi Lido,
so why dont you simply share your info and provide the link?
i am personally quite optimistic, too - but without addtl funding it will be difficult to pay out and get rid of cornell
and on the other side spread the brand prehistin effectively.
best, pix